Patent Assignment
Reel/Frame 060838/0852
Merger and Change of Name
Recorded: 2022-06-08
Pages: 4
Assignors
FRED HUTCHINSON CANCER RESEARCH CENTER
Executed: 2022-03-31
SEATTLE CANCER CARE ALLIANCE
Executed: 2022-03-31
Assignee
FRED HUTCHINSON CANCER CENTER
1100 FAIRVIEW AVE. N., SEATTLE, WASHINGTON, 98109
Covered Properties
(49)
Inhibition of Lymphocyte Adherence with Cs-1- Peptides and Fragments Thereof
Patent:
7,238,668 →
Application:
08/452,098 →
Compositions and Methods for Modulating Apoptosis in Cells Over-Expressing Bcl-2 Family Member Proteins
Patent:
7,241,804 →
Application:
10/069,431 →
Methods for Immortalizing Cells
Methods and Materials for Canine Breed Identification
Vectors for Expressing in Vivo Biotinylated Recombinant Proteins
Methods for Immortalizing Cells
Methods and Materials for Canine Breed Identification
Application:
13/039,240 →
Publication:
US 2011/0224911
Compositions and Methods for Generating Adeno-Associated Viral Vectors with Undetectable Capsid Gene Contamination
Compositions and Methods for Expansion of Embryonic Hematopoietic Stem Cells
Compounds and Methods for Preventing or Treating Sensory Hair Cell Death
Compositions and Methods for Generating Adeno-Associated Viral Vectors with Undetectable Capsid Gene Contamination
Compounds and Methods for Preventing, Treating and/or Protecting Against Sensory Hair Cell Death
Expansion and Engraftment of Stem Cells Using Notch 1 and/or Notch 2 Agonists
Compounds and Methods for Preventing or Treating Sensory Hair Cell Death
Expansion and Engraftment of Stem Cells Using Notch 1 and/or Notch 2 Agonists
Bi-Specific Molecule for Cell-Specific Notch Inhibition and Related Methods and Compositions
Compositions and Methods for Providing Hematopoietic Function Without Hla Matching
Application:
16/378,206 →
Publication:
US 2019/0298777
Compositions and Methods for Providing Hematopoietic Function Without Hla Matching
Application:
16/378,229 →
Publication:
US 2019/0298778
Modified Hematopoietic Stem/Progenitor and Non-T Effector Cells, and Uses Thereof
Application:
16/445,053 →
Publication:
US 2019/0381104
Systems and Methods for Hematopoietic Cell Expansion Utilizing Hydrogels
Application:
16/480,481 →
Publication:
US 2020/0009194
High Efficiency Targeted in Situ Genome-Wide Profiling
Compositions and Methods for Expansion of Embryonic Hematopoietic Stem Cells
Bispecific Antibodies Specific for Treating Hematological Malignancies
Compositions and Methods for Generating Adeno-Associated Viral Vectors with Undetectable Capsid Gene Contamination
Application:
16/943,770 →
Publication:
US 2021/0010027
Bispecific Affinity Reagent and Related Methods for Pretargeted Radioimmunotherapy Against CD45+ Cells
Application:
17/260,205 →
Publication:
US 2021/0269526
Methods and Compositions for Treating Cancer
Application:
17/264,713 →
Publication:
US 2022/0202845
Methods and Compositions for Adoptive T Cell Therapy Incorporating Induced Notch Signaling
Application:
17/272,117 →
Publication:
US 2021/0292711
Pharmacoproteomics Platform Identifying Kinome Features Regulating Drug Response in Cancer
Application:
17/313,512 →
Publication:
US 2021/0348171
Hydrogel Compositions and Methods for Treatment of Malignancies
Application:
17/434,390 →
Publication:
US 2022/0143210
Identification and Treatment of T-Cell Epitopes of Short H2A Oncohistones
Bio-Specimen Refrigeration System
Microlumenal Targeting of Cancer Cells
Application:
17/619,403 →
Publication:
US 2022/0257632
Methods and Compositions Comprising BRD9 Activating Therapies for Treating Cancers and Related Disorders
Application:
17/621,429 →
Publication:
US 2023/0159920
Methods and Compositions for Treating Androgen Receptor Deficient, Androgen Receptor Low, and Castration-Resistant Prostate Cancers
Methods and Compositions for Inducing Notch Signaling in Tumor Microenvironments
Application:
17/631,399 →
Publication:
US 2022/0267437
Method for Analyzing the Ability of Target Nucleic Acid Sequences to Impact Gene Expression
Application:
63/219,688 →
Anti-CD123 Affinity Reagents and Related Methods for Targeted Radioimmunotherapy for the Treatment of Acute Leukemia and Other CD123+ Neoplasms
Application:
63/274,623 →
DUX4 Polypeptides and Nucleic Acids for Treating Inflammatory and Autoimmune Conditions
Application:
63/278,814 →
Synthetic Constructs and Methods for Processing Antigen-Specific Cells
Application:
63/286,723 →
Olverembatinib Inhibits SARS-CoV2-Omicron Variant-Mediated Cytokine Release
Application:
63/306,757 →
Antibody-Based Compositions for Targeting Tropomyosin Receptor Kinase B (Trkb) Isoforms
PCT:
PCT/US2021/015699 ↗
Tunable Extended Release Hydrogels
PCT:
PCT/US2021/019937 ↗
Neutralizing Monoclonal Antibodies Against Covid-19
PCT:
PCT/US2021/029216 ↗
Compositions and Methods for Enhancing Cancer Immunotherapy
PCT:
PCT/US2021/032522 ↗
Anti-Fibrotic Composition and Related Methods
PCT:
PCT/US2021/033080 ↗
Improved High Efficiency Targeted in Situ Genome-Wide Profiling
PCT:
PCT/US2021/049944 ↗
Specific Targeting of Tumor-Infiltrating Regulatory T Cells (Tregs) Using Icos and Il-1R1
PCT:
PCT/US2021/054978 ↗
Synthetic Introns for Targeted Gene Expression
PCT:
PCT/US2021/056273 ↗
Treatment for Hsv-1 Using a Meganuclease
PCT:
PCT/US2022/013757 ↗
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 29, 2003
From: BERNSTEIN, IRWIN D.; VARNUM-FINNEY, BARBARA
To: FRED HUTCHISON CANCER RESEARCH CENTER
Reel/Frame 014535/0084 →
Assignment of Assignor's Interest
Feb 9, 2005
From: HOCKENBERY, DAVID M.; SIMON, JULIAN A.; TZUNG, SHIE-PON
To: FRED HUTCHINSON CANCER RESEARCH CENTER
Reel/Frame 015668/0882 →
Assignment of Assignor's Interest
Jan 31, 2006
From: OSTRANDER, ELAINE; KRUGLYAK, LEONID; PARKER, HEIDI G.; KIM, LISA V.
To: FRED HUTCHINSON CANCER RESEARCH CENTER
Reel/Frame 017098/0381 →
Assignment of Assignor's Interest
Oct 11, 2007
From: SCHOLLER, NATHALIE; GARVIK, BARBARA M.
To: FRED HUTCHINSON CANCER RESEARCH CENTER
Reel/Frame 019949/0953 →
Executive Order 9424, Confirmatory License
Jul 9, 2008
From: FRED HUTCHINSON CANCER RESEARCH CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021210/0374 →
Confirmatory License
Jul 19, 2010
From: FRED HUTCHINSON CANCER RESEARCH CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024697/0571 →
Assignment of Assignor's Interest
Mar 25, 2016
From: BERNSTEIN, IRWIN D.; HADLAND, BRANDON K.
To: FRED HUTCHINSON CANCER RESEARCH CENTER
Reel/Frame 038262/0420 →
Assignment of Assignor's Interest
Jun 17, 2016
From: SIMON, JULIAN
To: FRED HUTCHINSON CANCER RESEARCH CENTER
Reel/Frame 038944/0912 →
Assignment of Assignor's Interest
Jun 17, 2016
From: RUBEL, EDWIN W.; RAIBLE, DAVID W.
To: UNIVERSITY OF WASHINGTON
Reel/Frame 039072/0205 →
Assignment of Assignor's Interest
Jun 17, 2016
From: GONZALEZ, MARIO D.; MELTZER, PETER C.; MIAO, WEISHI; JOHNSON, GRAHAM
To: ORICULA THERAPEUTICS LLC
Reel/Frame 039072/0192 →
Assignment of Assignor's Interest
Aug 23, 2016
From: OHISHI, KOHSHI
To: FRED HUTCHINSON CANCER RESEARCH CENTER
Reel/Frame 039512/0832 →
Assignment of Assignor's Interest
Aug 23, 2016
From: OHISHI, KOHSHI
To: FRED HUTCHINSON CANCER RESEARCH CENTER
Reel/Frame 039512/0939 →
Confirmatory License
Oct 31, 2016
From: FRED HUTCHINSON CANCER RESEARCH CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 040513/0134 →
Confirmatory License
Oct 31, 2016
From: FRED HUTCHINSON CANCER RESEARCH CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 040513/0143 →
Confirmatory License
Nov 4, 2016
From: FRED HUTCHINSON CANCER RESEARCH CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 040568/0722 →
Confirmatory License
Nov 9, 2016
From: FRED HUTCHINSON CANCER RESEARCH CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 040579/0746 →
Confirmatory License
Dec 5, 2016
From: FRED HUTCHINSON CANCER RESEARCH CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 040807/0754 →
Confirmatory License
Dec 13, 2016
From: FRED HUTCHINSON CANCER RESEARCH CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 040900/0727 →
Confirmatory License
Jan 4, 2017
From: FRED HUTCHINSON CANCER RESEARCH CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 041239/0508 →
Confirmatory License
Jan 23, 2017
From: UNIVERSITY OF WASHINGTON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 041061/0181 →
Confirmatory License
Feb 9, 2017
From: FRED HUTCHINSON CANCER RESEARCH CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 041666/0493 →
Assignment of Assignor's Interest
Mar 15, 2017
From: BERNSTEIN, IRWIN D.
To: FRED HUTCHINSON CANCER RESEARCH CENTER
Reel/Frame 041586/0872 →
Assignment of Assignor's Interest
Jun 29, 2017
From: MILLER, ARTHUR DUSTY; HALBERT, CHRISTINE L.; METZGER, MICHAEL J.
To: FRED HUTCHINSON CANCER RESEARCH CENTER
Reel/Frame 042869/0142 →
Confirmatory License
Aug 18, 2017
From: UNIVERSITY OF WASHINGTON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 043602/0943 →
Confirmatory License
Nov 15, 2017
From: UNIVERSITY OF WASHINGTON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 044455/0193 →